drugset / Trial / NCT03223519
COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)
Phase 2
Completed
74 enrolled
Spherium Biomed
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is designed as a proof of concept, single-center, randomized, double-blind, placebo controlled study to assess the safety and efficacy of Comboprofen (Ibuprofen + Magnesium + Vitamin C) compared to placebo, Ibuprofen, Magnesium and Vitamin C monotherapies in the treatment of Delayed Onset Muscle Soreness (DOMS).
Timeline
- Start
- 2017-07-12
- Primary completion
- 2017-11-24
- Completion
- 2017-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ibuprofen | Small molecule | — | Oral |
| Comparator | Magnesium Sulfate | Other / unclassified | — | Oral |
| Comparator | Vitamin C | Other / unclassified | — | Oral |
Indications
No indication recorded.